Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compositions for inhibiting checkpoint gene expression and uses thereof

Compositions for inhibiting checkpoint gene expression and uses thereof

US Patent 9828601 · Granted Nov 28, 2017

Estimated economic value: $6,795,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions and methods for kallikrein (KLKB1) gene editing2025
Therapeutic compositions for treating pain via multiple targets2024
Compositions and methods for TTR gene editing and treating ATTR amyloidosis2024
Compositions and methods for TTR gene editing and treating ATTR amyloidosis2023
Compositions and methods for inhibiting TIGIT gene expression2022
Immune modulation with TLR9 agonists for cancer treatment2022
Immune modulation with TLR9 agonists for cancer treatment2022
Immune modulation with TLR9 agonists for cancer treatment2022
Immune modulation with TLR9 agonists for cancer treatment2020
Immune modulation with TLR9 agonists for cancer treatment2020
Immune modulation with TLR9 agonists for cancer treatment2020
Immune modulation with TLR9 agonists for cancer treatment2020